GI
EDIT icon

GAMMA Investing’s Editas Medicine EDIT Stock Holding History

GAMMA Investing’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.15K Buy
1,282
+82
+7% +$240 ﹤0.01% 3549
2026
Q1 		$2.96K Buy
1,200
+652
+119% +$1.38K ﹤0.01% 3551
2025
Q4 		$1.12K Buy
+548
New +$1.58K ﹤0.01% 3757
2024
Q4 		– Sell
-137
Closed -$467 – 3792
2024
Q3 		$467 Sell
137
-1,381
-91% -$6.01K ﹤0.01% 3404
2024
Q2 		$7.09K Buy
1,518
+793
+109% +$4.47K ﹤0.01% 2415
2024
Q1 		$5.38K Buy
725
+176
+32% +$1.46K ﹤0.01% 2381
2023
Q4 		$3.86K Buy
+549
New +$4.82K ﹤0.01% 2345

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

GAMMA Investing's EDIT Position: Q2 2026 in Review

GAMMA Investing increased its Editas Medicine (EDIT) stake by 6.8% in Q2 2026, buying an estimated $240 and bringing the position to 1,282 shares worth $4.15K. The position accounts for ﹤0.01% of the portfolio, ranked #3549.

GAMMA Investing first reported a position in EDIT in Q4 2023 and has held it in 7 quarters since. The position peaked at $7.09K in Q2 2024. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • GAMMA Investing held 1,282 shares of Editas Medicine worth $4.15K as of Q2 2026.
  • GAMMA Investing bought 82 Editas Medicine shares in Q2 2026, an estimated $240.
  • Editas Medicine made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3549 holding.
  • GAMMA Investing first reported a position in Editas Medicine in Q4 2023 and has held it in 7 quarters since.
  • GAMMA Investing's Editas Medicine position peaked at $7.09K in Q2 2024.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.